Stockreport

LogicBio IPO: Undervalued, But Phase 1/2 Clinical Trial Will Commence By The End Of 2019 [Seeking Alpha]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF Summary LogicBio ( LOGC ) seems cheap as compared to peers conducting similar research. The company is expected to have a market capitalization of $269 million, whi [Read more]